Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy

Sangiliyandi Gurunathan, Jae Woong Han, Jung Hyun Park, Eunsu Kim, Yun-Jung Choi, Deug-Nam Kwon, Jin-Hoi Kim Department of Animal Biotechnology, Konkuk University, Seoul, Republic of Korea Background: Graphene and graphene-based nanocomposites are used in various research areas including...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gurunathan S, Han JW, Park JH, Kim E, Choi YJ, Kwon DN, Kim JH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/7daeff4616c444a5a0765b88e52264e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7daeff4616c444a5a0765b88e52264e1
record_format dspace
spelling oai:doaj.org-article:7daeff4616c444a5a0765b88e52264e12021-12-02T04:05:36ZReduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy1178-2013https://doaj.org/article/7daeff4616c444a5a0765b88e52264e12015-10-01T00:00:00Zhttps://www.dovepress.com/reduced-graphene-oxidendashsilver-nanoparticle-nanocomposite-a-potenti-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Sangiliyandi Gurunathan, Jae Woong Han, Jung Hyun Park, Eunsu Kim, Yun-Jung Choi, Deug-Nam Kwon, Jin-Hoi Kim Department of Animal Biotechnology, Konkuk University, Seoul, Republic of Korea Background: Graphene and graphene-based nanocomposites are used in various research areas including sensing, energy storage, and catalysis. The mechanical, thermal, electrical, and biological properties render graphene-based nanocomposites of metallic nanoparticles useful for several biomedical applications. Epithelial ovarian carcinoma is the fifth most deadly cancer in women; most tumors initially respond to chemotherapy, but eventually acquire chemoresistance. Consequently, the development of novel molecules for cancer therapy is essential. This study was designed to develop a simple, non-toxic, environmentally friendly method for the synthesis of reduced graphene oxide–silver (rGO–Ag) nanoparticle nanocomposites using Tilia amurensis plant extracts as reducing and stabilizing agents. The anticancer properties of rGO–Ag were evaluated in ovarian cancer cells. Methods: The synthesized rGO–Ag nanocomposite was characterized using various analytical techniques. The anticancer properties of the rGO–Ag nanocomposite were evaluated using a series of assays such as cell viability, lactate dehydrogenase leakage, reactive oxygen species generation, cellular levels of malonaldehyde and glutathione, caspase-3 activity, and DNA fragmentation in ovarian cancer cells (A2780). Results: AgNPs with an average size of 20 nm were uniformly dispersed on graphene sheets. The data obtained from the biochemical assays indicate that the rGO–Ag nanocomposite significantly inhibited cell viability in A2780 ovarian cancer cells and increased lactate dehydrogenase leakage, reactive oxygen species generation, caspase-3 activity, and DNA fragmentation compared with other tested nanomaterials such as graphene oxide, rGO, and AgNPs. Conclusion: T. amurensis plant extract-mediated rGO–Ag nanocomposites could facilitate the large-scale production of graphene-based nanocomposites; rGO–Ag showed a significant inhibiting effect on cell viability compared to graphene oxide, rGO, and silver nanoparticles. The nanocomposites could be effective non-toxic therapeutic agents for the treatment of both cancer and cancer stem cells. Keywords: graphene–silver nanocomposites, silver nanoparticles, ovarian cancer cells, cancer stem cells, cell viability, caspase-3Gurunathan SHan JWPark JHKim EChoi YJKwon DNKim JHDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 6257-6276 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Gurunathan S
Han JW
Park JH
Kim E
Choi YJ
Kwon DN
Kim JH
Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
description Sangiliyandi Gurunathan, Jae Woong Han, Jung Hyun Park, Eunsu Kim, Yun-Jung Choi, Deug-Nam Kwon, Jin-Hoi Kim Department of Animal Biotechnology, Konkuk University, Seoul, Republic of Korea Background: Graphene and graphene-based nanocomposites are used in various research areas including sensing, energy storage, and catalysis. The mechanical, thermal, electrical, and biological properties render graphene-based nanocomposites of metallic nanoparticles useful for several biomedical applications. Epithelial ovarian carcinoma is the fifth most deadly cancer in women; most tumors initially respond to chemotherapy, but eventually acquire chemoresistance. Consequently, the development of novel molecules for cancer therapy is essential. This study was designed to develop a simple, non-toxic, environmentally friendly method for the synthesis of reduced graphene oxide–silver (rGO–Ag) nanoparticle nanocomposites using Tilia amurensis plant extracts as reducing and stabilizing agents. The anticancer properties of rGO–Ag were evaluated in ovarian cancer cells. Methods: The synthesized rGO–Ag nanocomposite was characterized using various analytical techniques. The anticancer properties of the rGO–Ag nanocomposite were evaluated using a series of assays such as cell viability, lactate dehydrogenase leakage, reactive oxygen species generation, cellular levels of malonaldehyde and glutathione, caspase-3 activity, and DNA fragmentation in ovarian cancer cells (A2780). Results: AgNPs with an average size of 20 nm were uniformly dispersed on graphene sheets. The data obtained from the biochemical assays indicate that the rGO–Ag nanocomposite significantly inhibited cell viability in A2780 ovarian cancer cells and increased lactate dehydrogenase leakage, reactive oxygen species generation, caspase-3 activity, and DNA fragmentation compared with other tested nanomaterials such as graphene oxide, rGO, and AgNPs. Conclusion: T. amurensis plant extract-mediated rGO–Ag nanocomposites could facilitate the large-scale production of graphene-based nanocomposites; rGO–Ag showed a significant inhibiting effect on cell viability compared to graphene oxide, rGO, and silver nanoparticles. The nanocomposites could be effective non-toxic therapeutic agents for the treatment of both cancer and cancer stem cells. Keywords: graphene–silver nanocomposites, silver nanoparticles, ovarian cancer cells, cancer stem cells, cell viability, caspase-3
format article
author Gurunathan S
Han JW
Park JH
Kim E
Choi YJ
Kwon DN
Kim JH
author_facet Gurunathan S
Han JW
Park JH
Kim E
Choi YJ
Kwon DN
Kim JH
author_sort Gurunathan S
title Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
title_short Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
title_full Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
title_fullStr Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
title_full_unstemmed Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
title_sort reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/7daeff4616c444a5a0765b88e52264e1
work_keys_str_mv AT gurunathans reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT hanjw reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT parkjh reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT kime reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT choiyj reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT kwondn reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
AT kimjh reducedgrapheneoxidendashsilvernanoparticlenanocompositeapotentialanticancernanotherapy
_version_ 1718401439533891584